Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vinorelbine Versus Gemcitabine Versus Gemcitabine and Vinorelbine in Elderly Patients With Stage IIIB-IV Non-Small Cell Lung Cancer

NCT00003447 is registered in ClinicalTrials.gov with Istituto Nazionale per lo Studio e la Cura dei Tumori as lead sponsor.

NCT NCT00003447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vinorelbine Versus Gemcitabine Versus Gemcitabine and Vinorelbine in Elderly Patients With Stage IIIB-IV Non-Small Cell Lung Cancer
Lead sponsor
Istituto Nazionale per lo Studio e la Cura dei Tumori
Phase
Phase 3
Overall status
Unknown status
Start date
July 31, 1998
Completion date
Not reported
Enrollment
630 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer